Article By:
Terry Chrisomalis
Friday, November 6, 2015 9:45 AM EDT
Today AstraZeneca (AZN) announced that it will acquire ZS Pharma (ZSPH) for $2.7 billion. According to the deal, AZN will acquire ZSPH for $90 per share in an all cash transaction.